Literature DB >> 25401491

Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.

Paweł Cieślik1, Antoni Hrycek.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder with organ injury related to vasculitis. Inflammation of blood vessels results from auto-immunological activation of endothelial cells. The pentraxin 3 (PTX3), might act as an indicator of vasculitides in many diseases. The aim of this study was to determine whether PTX3 might be useful as a marker of vascular injury in SLE. This study was carried out in a group of 56 SLE women, and in the 28 female volunteers control group. All participants' plasma and serum samples were collected to estimate concentrations (ELISA) of PTX3, soluble thrombomodulin, soluble E-selectin (sE-selectin), soluble P-selectin (sP-selectin), soluble form of vascular cell adhesion molecule 1 (sVCAM-1), soluble inter-cellular adhesion molecule-1 (sICAM-1), soluble platelet endothelial cell adhesion molecule 1, monocyte chemotactic protein-1 (MCP-1) and von Willebrand factor (vWF) activity. Anthropometric, demographic and lifestyle characteristics of SLE patients were also performed. The SLE patients had higher PTX3, vWF, MCP-1, sE-selectin and sVCAM-1 levels than the controls (1.82 ± 1.56 ng/mL, 237 ± 101%, 70.05 ± 18.31 ng/mL, 111.16 ± 49.15 ng/mL and 978.78 ± 462.35 ng/mL vs. 0.86 ± 0.40 ng/mL, 138 ± 43%, 58.56 ± 13.91 ng/mL, 66.04 ± 27.18 ng/mL and 499.07 ± 125.67 ng/mL, respectively). The independent factors affecting PTX3 expression included Systemic Lupus Erythematosus Disease Activity Index, prednisone dose and anemia severity. Moreover, the PTX3 areas under the curve-receiver operating characteristics curves 0.717 ± 0.056 with cut-off level of 1.96 ng/mL was comparable to vWF, MCP-1, sE-selectin, sP-selectin and sICAM-1. PTX3 and sVCAM-1 were the only factors related to SLE activity. Other vascular injury indicators associated with PTX3 were vWF and sVCAM-1. In conclusion, PTX3 concentrations in SLE patients might serve as a indicator of the activation/dysfunction of vascular endothelium.

Entities:  

Keywords:  Biomarker; Pentraxin 3; SLEDAI; lupus; vasculitis

Mesh:

Substances:

Year:  2014        PMID: 25401491     DOI: 10.3109/08916934.2014.983264

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  13 in total

1.  Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.

Authors:  Ufuk İlgen; Müçteba Enes Yayla; Nurşen Düzgün
Journal:  Clin Rheumatol       Date:  2016-11-22       Impact factor: 2.980

2.  Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.

Authors:  Sefa Ciftci; Huseyin Tugrul Celik; Pinar Atukeren; Nurdan Ciftci; Mustafa Saygin Deniz; Yasemin Coskun Yavuz; Fatmanur Hacievliyagil Kazanci; Sümeyye Gök; Hilmi Demirin; Muhammet Ramazan Yigitoglu
Journal:  J Clin Lab Anal       Date:  2016-05-26       Impact factor: 2.352

3.  Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Authors:  L Wirestam; H Enocsson; T Skogh; M L Eloranta; L Rönnblom; C Sjöwall; J Wetterö
Journal:  Clin Exp Immunol       Date:  2017-03-31       Impact factor: 4.330

Review 4.  Cardiovascular Outcomes in Systemic Lupus Erythematosus.

Authors:  Shrilekha Sairam; Amit Sureen; Jesus Gutierrez; The Q Dang; Kunal Mishra
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

Review 5.  Endothelial cells: potential novel regulators of renal inflammation.

Authors:  Jim C Oates; Dayvia L Russell; Justin P Van Beusecum
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-07

Review 6.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 7.  Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Authors:  Vítor Teixeira; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2018-01-29

Review 8.  Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction.

Authors:  Laura Atehortúa; Mauricio Rojas; Gloria M Vásquez; Diana Castaño
Journal:  Mediators Inflamm       Date:  2017-05-04       Impact factor: 4.711

9.  PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.

Authors:  Pei Mou; Ziyu Chen; Lihong Jiang; Jinwei Cheng; Ruili Wei
Journal:  Biomed Res Int       Date:  2018-02-20       Impact factor: 3.411

10.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.